Concepedia

Stephen T. Schlachter

ST

13

Publications

1.1K

Citations

13

H-Index

1988

Active since

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

Array BioPharma (United States)

Stephen T. Schlachter is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1988–2023

13

Publications

13

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Eli M. Wallace, James P. Rizzi, Guangzhou Han et al. · Cancer Research · 2016 · 310 citations

Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors

James F. Blake, Rui Xu, Josef R. Bencsik et al. · Journal of Medicinal Chemistry · 2012 · 184 citations · Full text

, , +15

Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents

Richard A. Nugent, Megan Murphy, Stephen T. Schlachter et al. · Journal of Medicinal Chemistry · 1993 · 116 citations

Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (<i>S</i>)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1<i>H</i>-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)

Paul M. Wehn, James P. Rizzi, Darryl D. Dixon et al. · Journal of Medicinal Chemistry · 2018 · 108 citations · Full text

DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer.

Adam Kashishian, Heather Douangpanya, Darcey Clark et al. · PubMed · 2003 · 92 citations

, , +15

Rows per page

1–5 of 13